Loading data for PBM — first visit, this takes a few seconds.
Psyence Biomedical Ltd. (PBM)
NasdaqCM: PBM
· リアルタイム株価 · USD
4.33
+0.40 (10.18%)
終値時点: Aug 25, 2026, 3:52 PM
株価、主要な数字、最新ニュースをひとまとめにしたページです。
Psyence Biomedical Ltd.(PBM)の株価・分析・データ
10.18% (1D)
データがありません
PBMについて
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc....
企業情報の全文2ページ中1ページ